Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Granite Awarded $48 Million Construction Manager/General Contractor Bridge Contract in California: https://mms.businesswire.com/media/20191118005918/en/662198/5/Granite-Logo-Color.jpg
Granite Awarded $48 Million Construction Manager/General Contractor Bridge Contract in California


Granite (NYSE:GVA) has been awarded the Cosumnes Bridge Parent Package of the Construction Manager/General Contractor (CMGC) contract for the Cosumnes Bridge Replacement Project by the California

The First Bancshares, Inc. Announces Extension of Exchange Offer: https://mms.businesswire.com/media/20191101005101/en/60698/5/Logo_Holding.jpg
The First Bancshares, Inc. Announces Extension of Exchange Offer


The First Bancshares, Inc. (NASDAQ: FBMS) (“First Bancshares” or the “Company”), the holding company for The First, A National Banking Association, announced today that it has extended its offer to

 
OL GROUPE : DISCLOSURE OF TOTAL NUMBER OF VOTING RIGHTS AND NUMBER OF SHARES IN THE CAPITAL AT 11/30/20
OL GROUPE : DISCLOSURE OF TOTAL NUMBER OF VOTING RIGHTS AND NUMBER OF SHARES IN THE CAPITAL AT 11/30/20

Pursuant to article L. 233-8 of the French « Code de Commerce » and 223-16 of the AMF's General Regulation

Total number of shares 58 206 656 Number of real voting rights 92 585 000
AbCellera-Discovered Antibody Prevented COVID-19 in Nursing Homes and Reduced Risks by up to 80% for Residents: https://mms.businesswire.com/media/20210119006096/en/705128/5/AbCellera_Full_Colour_RGB_1.jpg
AbCellera-Discovered Antibody Prevented COVID-19 in Nursing Homes and Reduced Risks by up to 80% for Residents


AbCellera (Nasdaq: ABCL) today announced that bamlanivimab (LY-CoV555), a human antibody discovered by AbCellera and developed with Eli Lilly and Company (Lilly), significantly reduced the risk of

Iteris Sets Fiscal Third Quarter 2021 Conference Call for Tuesday, February 2, 2021 at 4:30 p.m. ET: https://mms.businesswire.com/media/20191105005167/en/545349/5/Iteris_Logo_black.jpg
Iteris Sets Fiscal Third Quarter 2021 Conference Call for Tuesday, February 2, 2021 at 4:30 p.m. ET


Iteris, Inc. (NASDAQ: ITI), the global leader in smart mobility infrastructure management, today announced that it will conduct a conference call on Tuesday, February 2 at 4:30 p.m. Eastern time

Semtech and Meshed Leverage the LoRaWAN® Protocol to Monitor City Public Health
Semtech and Meshed Leverage the LoRaWAN® Protocol to Monitor City Public Health


Semtech Corporation (Nasdaq: SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, announced that Meshed Pty Ltd (Meshed IoT Integrators)

Lineage Posts Series of Webinars Highlighting Recent Progress With its Three Clinical-Stage Allogeneic Cell Transplant Programs : https://mms.businesswire.com/media/20191210005404/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg
Lineage Posts Series of Webinars Highlighting Recent Progress With its Three Clinical-Stage Allogeneic Cell Transplant Programs


Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies to address unmet medical needs, recently highlighted to

NGL Energy Partners LP Announces $2.05 Billion Offering of Senior Secured Notes: https://mms.businesswire.com/media/20191101005106/en/274573/5/NGLEP_Blue_Logo.jpg
NGL Energy Partners LP Announces $2.05 Billion Offering of Senior Secured Notes


NGL Energy Partners LP (NYSE: NGL) (“NGL”), through its wholly owned subsidiaries NGL Energy Operating LLC and NGL Energy Finance Corp., today announced that they intend to offer, subject to market

Newron Completes Enrollment of Explanatory Safety and Efficacy Study With Evenamide in Schizophrenia Patients : https://mms.businesswire.com/media/20200216005057/en/682845/5/logo_color_high_res.jpg
Newron Completes Enrollment of Explanatory Safety and Efficacy Study With Evenamide in Schizophrenia Patients


Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral

Kinder Morgan to Hold 2021 Investor Day: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24198/Kinder_Morgan_logo.svg.png
Kinder Morgan to Hold 2021 Investor Day


Representatives of Kinder Morgan, Inc. (KMI) intend to make virtual presentations on January 27, 2021 at the Kinder Morgan 2021 Investor Day regarding the results for fiscal year 2020, the

Fifth Third Announces Fourth Quarter 2020 Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24455/Fifth_Third_Bank.svg_%281%29.png
Fifth Third Announces Fourth Quarter 2020 Results


Fifth Third Bancorp (FITB):



Key Highlights




  • CET1 approx. 84 bps above target; positioned to initiate repurchases up to $180 million in 1Q21




  • Solid credit quality, with stable NCOs and

NeXR Technologies SE and H&Mbeyond. Start Cooperation on Virtual Fitting
NeXR Technologies SE and H&Mbeyond. Start Cooperation on Virtual Fitting


NeXR Technologies SE (XETRA: NXR) takes further steps in the development of innovation for stationary retail and enters into a groundbreaking cooperation with H&Mbeyond. The aim of the cooperation

First Head & Neck Cancer Patient Treated in France in a Phase I Trial With TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy : https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
First Head & Neck Cancer Patient Treated in France in a Phase I Trial With TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy


Regulatory News:



Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces that a first patient with

Western Union Expands in South Korea with NH Investment & Securities: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24835/375px-Western_Union_money_transfer.png
Western Union Expands in South Korea with NH Investment & Securities


Western Union, a global leader in cross-border, cross-currency money movement and payments, and NH Investment & Securities (NH I&S), one of the largest investment and securities companies in South

NGL Energy Partners Announces Quarterly Class D Distribution: https://mms.businesswire.com/media/20191101005106/en/274573/5/NGLEP_Blue_Logo.jpg
NGL Energy Partners Announces Quarterly Class D Distribution


NGL Energy Partners LP (NYSE: NGL) announced today that the Board of Directors of its general partner has declared a quarterly distribution in the required amount of $15.6 million, which amount

Nutrien Announces Release Dates for Fourth Quarter 2020 Results and Conference Call: https://mms.businesswire.com/media/20191104006030/en/699432/5/Nutrien_logo.jpg
Nutrien Announces Release Dates for Fourth Quarter 2020 Results and Conference Call


Nutrien Ltd (TSX and NYSE: NTR) announced today plans to release fourth quarter earnings results on Wednesday, February 17, 2021, after market close. Nutrien will host a conference call the

TechnipFMC to Host Capital Markets Day Dedicated to Technip Energies on January 28, 2021: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24460/FMC_Technologies_%28logo%29.png
TechnipFMC to Host Capital Markets Day Dedicated to Technip Energies on January 28, 2021


Regulatory News:



TechnipFMC plc (NYSE:FTI) (PARIS:FTI) (ISIN:GB00BDSFG982) (the “Company” or “TechnipFMC”) today announced that it will host a Capital Markets Day dedicated to Technip Energies

QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus
QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced its polymerase chain reaction (PCR) tests remain accurate and effective in detecting SARS-CoV-2 infections – and will

The First Bancorp Reports Results for 2020
The First Bancorp Reports Results for 2020


The First Bancorp (Nasdaq: FNLC), parent company of First National Bank, today announced operating results for the year ended December 31, 2020. Unaudited net income was $27.1 million, up $1.6

Lineage Cell Therapeutics Announces Change to Executive Team : https://mms.businesswire.com/media/20191210005404/en/737852/5/LINEAGE_SCREEN_JPEG_1800x360.jpg
Lineage Cell Therapeutics Announces Change to Executive Team


Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brandi

First Internet Bancorp Reports Fourth Quarter and Full Year 2020 Results: https://mms.businesswire.com/media/20191101005573/en/288424/5/FIBancorp_Logo_2011.jpg
First Internet Bancorp Reports Fourth Quarter and Full Year 2020 Results


First Internet Bancorp (the “Company”) (Nasdaq: INBK), the parent company of First Internet Bank (the “Bank”), announced today financial and operational results for the fourth quarter and full year

NextDecade Announces Appointment of Brent Wahl as Chief Financial Officer
NextDecade Announces Appointment of Brent Wahl as Chief Financial Officer


NextDecade Corporation (NextDecade or the Company) (NASDAQ: NEXT) today announced that the Board of Directors has appointed Brent E. Wahl as Chief Financial Officer effective February 1, 2021. Mr

QIAGEN Plans to Resubmit EUA Submission in the U.S. for QIAreach SARS-CoV-2 Antigen Test in the First Quarter of 2021
QIAGEN Plans to Resubmit EUA Submission in the U.S. for QIAreach SARS-CoV-2 Antigen Test in the First Quarter of 2021


QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it plans to resubmit in the first quarter of 2021 its QIAreach SARS-CoV-2 Antigen Test to the U.S. Food and Drug

Illumina Wins Patent Infringement Suit against BGI in the UK
Illumina Wins Patent Infringement Suit against BGI in the UK


Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI

Discover Financial Services Reports Fourth Quarter Net Income of $799 Million or $2.59 Per Diluted Share: https://mms.businesswire.com/media/20191118005067/en/756953/5/Discover_NHL_092019v2_lock_up_2020.jpg
Discover Financial Services Reports Fourth Quarter Net Income of $799 Million or $2.59 Per Diluted Share


Discover Financial Services (NYSE: DFS):


Fourth Quarter Results


 


2020


 


2019


 


YOY Change


Total loans, end of period (in billions)


$90.4


 


$95.9